0001209191-16-096102.txt : 20160205 0001209191-16-096102.hdr.sgml : 20160205 20160205190026 ACCESSION NUMBER: 0001209191-16-096102 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160203 FILED AS OF DATE: 20160205 DATE AS OF CHANGE: 20160205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anacor Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001411158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251854385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: 650-543-7500 MAIL ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 FORMER COMPANY: FORMER CONFORMED NAME: Anacor Pharmaceuticals Inc DATE OF NAME CHANGE: 20070830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bell Graeme CENTRAL INDEX KEY: 0001643757 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34973 FILM NUMBER: 161393625 MAIL ADDRESS: STREET 1: 1324 WAVERLY ROAD CITY: GLADWYNE STATE: PA ZIP: 19035 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-02-03 0 0001411158 Anacor Pharmaceuticals, Inc. ANAC 0001643757 Bell Graeme C/O ANACOR PHARMACEUTICALS, INC. 1020 EAST MEADOW CIRCLE PALO ALTO CA 94303 0 1 0 0 Executive VP and CFO Common Stock 2016-02-03 4 A 0 5000 0.00 A 11006 D Stock Option (right to buy) 78.91 2016-02-03 4 A 0 25299 0.00 A 2026-02-03 Common Stock 25299 25299 D Performance Restricted Stock Units 2016-02-03 4 A 0 5000 0.00 A Common Stock 5000 5000 D Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2016. The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting each month thereafter. The Vesting Commencement Date is January 1, 2016. Represents performance restricted stock units granted to the Reporting Person. Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and will vest, if at all, based on the achievement of certain specified performance goals. /s/ John C. Duncanson, as attorney-in-fact 2016-02-05